NeuroServo

NeuroServo, a Canadian startup founded in 2015, specializes in next-generation EEG and Cerebral Function Monitoring with advanced pathology detection algorithms. The company has developed a miniaturized, non-intrusive, portable, instant-use, and motion-resistant brain wave capture device (EEG). This device captures brain waves and analyzes them in real-time using NeuroServo algorithms, enabling early detection of cerebral pathologies like delirium. The company recently secured a significant $2.20M in a Seed Round investment on 20 June 2023. This investment was led by Desjardins Capital, Investissement Québec, and the Center of Aging and Brain Health Innovation. This indicates a strong investor interest in NeuroServo's innovative technology and its potential impact in the healthcare industry. In an industry where early detection and monitoring of cerebral functions are critical, NeuroServo's technology presents promising solutions. The company's focus on advancing EEG capabilities and pathology detection can have a profound impact on the diagnosis and treatment of neurological conditions. With the substantial investment received, NeuroServo is well-positioned to further develop and commercialize its cutting-edge solutions, potentially reshaping the landscape of cerebral health monitoring.